| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 07/25/2002 | CA2435260A1 Receptors and membrane-associated proteins |
| 07/25/2002 | CA2435077A1 Preparation for improved dietary utilisation |
| 07/25/2002 | CA2434939A1 Urea derivatives as integrin alpha 4 antagonists |
| 07/25/2002 | CA2434866A1 Screening assay for cotranslational translocation interfering compounds |
| 07/25/2002 | CA2434736A1 Method of treatment of dopamine-related dysfunction through administration of a full d1 dopamine receptor agonist and with no induction of tolerance |
| 07/25/2002 | CA2434696A1 P27 prevents cellular migration |
| 07/25/2002 | CA2434636A1 Symmetrically disubstituted aromatic compounds and pharmaceutical compositions for inhibiting poly (adp-ribose) glycohydrolase, and methods for their use |
| 07/25/2002 | CA2434350A1 Novel receptors for $i(helicobacter pylori) and use thereof |
| 07/25/2002 | CA2433879A1 C-terminal modified oxamyl dipeptides as inhibitors of the ice/ced-3 family of cysteine proteases |
| 07/25/2002 | CA2433313A1 Polypetides and nucleic acids encoding same |
| 07/25/2002 | CA2430634A1 Proteins, polynucleotides encoding them and methods of using the same |
| 07/25/2002 | CA2430577A1 Compounds specific to adenosine a1, a2a, and a3 receptor and uses thereof |
| 07/25/2002 | CA2427058A1 Substituted felbamate derived compounds |
| 07/25/2002 | CA2369212A1 Combination therapy |
| 07/24/2002 | EP1225224A1 Shear stress-response dna |
| 07/24/2002 | EP1225183A2 Human G-protein coupled receptor |
| 07/24/2002 | EP1225170A2 Cycloheptene compounds, process for their preparation and pharmaceutical compositions containing them |
| 07/24/2002 | EP1225168A2 Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension |
| 07/24/2002 | EP1224942A1 Use of JAQ1 (monoclonal antibody anti GPVI) as a medicament for the protection against thrombotic diseases |
| 07/24/2002 | EP1224941A2 Antithrombin III used in diseases caused by angiogenesis |
| 07/24/2002 | EP1224935A2 Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension |
| 07/24/2002 | EP1224934A2 Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension |
| 07/24/2002 | EP1224932A1 Drugs inhibiting cell death |
| 07/24/2002 | EP1224461A2 Reagents and methods for diagnosing, imaging and treating atherosclerotic disease |
| 07/24/2002 | EP1224322A2 Gene sequence variations with utility in determining the treatment of disease |
| 07/24/2002 | EP1224302A2 Modified viral surface proteins which bind to cells of tumor vasculature |
| 07/24/2002 | EP1224288A2 Processed human chemokines phc-1 and phc-2 |
| 07/24/2002 | EP1224285A2 27 human secreted proteins |
| 07/24/2002 | EP1224283A2 Human and rat fgf-20 genes and gene expression products |
| 07/24/2002 | EP1224282A2 Novel polypeptides, their nucleic acids, and methods for their use in angiogenesis and vascularization |
| 07/24/2002 | EP1224281A1 37 human secreted proteins |
| 07/24/2002 | EP1224268A1 Methods for using 22045, a human cyclic nucleotide phosphodiesterase |
| 07/24/2002 | EP1224218A1 Dna encoding human alpha1g-c t-type calcium channel |
| 07/24/2002 | EP1224209A1 10 human secreted proteins |
| 07/24/2002 | EP1224208A1 Human inwardly rectifying potassium channel subunit |
| 07/24/2002 | EP1224207A1 5-hydroxysapogenin derivatives with anti-dementia activity |
| 07/24/2002 | EP1224205A1 5-beta-sapogenin and pseudosapogenin derivatives and their use in the treatment of dementia |
| 07/24/2002 | EP1224201A1 32 human secreted proteins |
| 07/24/2002 | EP1224200A1 Tissue plasminogen activator-like protease |
| 07/24/2002 | EP1224195A1 C-aryl glucoside sglt2 inhibitors |
| 07/24/2002 | EP1224187A2 Certain alkylene diamine-substituted heterocycles |
| 07/24/2002 | EP1224186A2 Pyridyl-containing spirocyclic compounds as inhibitors of fibrinogen-dependent platelet aggregation |
| 07/24/2002 | EP1224183A2 Heterocyclic sodium/proton exchange inhibitors and method |
| 07/24/2002 | EP1224179A2 Sodium-hydrogen exchanger type 1 inhibitor crystals |
| 07/24/2002 | EP1224175A2 Benzodiazepine derivatives as metabotropic glutamate receptor antagonists |
| 07/24/2002 | EP1224174A2 Benzodiazepine derivatives as metabotropic glutamate receptor antagonists |
| 07/24/2002 | EP1224173A1 Pyrazole derivatives as cannabinoid receptor antagonists |
| 07/24/2002 | EP1224172A1 Drugs for the treatment of malignant tumours |
| 07/24/2002 | EP1224171A1 Beta disubstituted metalloprotease inhibitors |
| 07/24/2002 | EP1224170A1 6-position substituted indoline, production and use thereof as a medicament |
| 07/24/2002 | EP1224166A1 Method of producing n-(4,5-bis-methanesulfonyl-2-methyl-benzoyl)-guanidine, the hydrochloride thereof |
| 07/24/2002 | EP1224163A1 Use of carbonylamino derivatives against cns disorders |
| 07/24/2002 | EP1224161A1 Nitroxy derivatives of (r) and (s)-carnitine |
| 07/24/2002 | EP1224155A2 Novel bicyclic cannabinoid agonists for the cannabinoid receptor |
| 07/24/2002 | EP1224022A1 Naturally extracted and synthetic hypoglycemic or hypolipidemic compositions |
| 07/24/2002 | EP1223977A2 Modified plant viruses and methods of use thereof |
| 07/24/2002 | EP1223965A2 Modulation of angiogenesis |
| 07/24/2002 | EP1223948A2 Method of inhibiting nf-kappa-b with heparin, for treating cardiovascular diseases and inflammations |
| 07/24/2002 | EP1223945A1 Compositions comprising oxophosphonate-based metalloproteinase inhibitors |
| 07/24/2002 | EP1223932A1 Compounds and methods |
| 07/24/2002 | EP1223931A1 Treatment or prevention of hypotension and shock |
| 07/24/2002 | EP1223929A1 Cannabimimetic indole derivatives |
| 07/24/2002 | EP1223925A2 Use of a fatty acid derivative for the treatment of external secretion disorders |
| 07/24/2002 | EP1223921A2 Tissue factor antagonists and methods of use thereof |
| 07/24/2002 | EP1223918A1 Pharmaceutical compositions comprising a hmg coa reductase inhibitor |
| 07/24/2002 | EP1223915A1 Dry powder compositions having improved dispersivity |
| 07/24/2002 | EP1102743B1 Amide derivatives which are useful as cytokine inhibitors |
| 07/24/2002 | EP1100767B1 Novel phenylethylamine derivatives, a method for the production thereof and their use as medicaments |
| 07/24/2002 | EP0983268B1 Amidine derivatives as inhibitors of nitric oxide synthase |
| 07/24/2002 | EP0966473B1 Thiazolobenzoheterocycles, preparation and medicines containing same |
| 07/24/2002 | EP0936910B1 Intracoronary stents containing quinazolinone derivatives |
| 07/24/2002 | EP0904110B1 Nitric oxide donors capable of reducing toxicity from drugs |
| 07/24/2002 | EP0900218B1 Heterocyclic compounds |
| 07/24/2002 | EP0886647B1 Serine protease inhibitors |
| 07/24/2002 | EP0835263B9 Somatostatin peptides |
| 07/24/2002 | EP0804431B1 GLYCOPROTEIN IIb/IIIa ANTAGONISTS |
| 07/24/2002 | EP0684945B1 Pyrazole- or isoxazole-substituted alkyl amide acat inhibitors |
| 07/24/2002 | CN1360629A Induction of vascular endothelial growth factor (VEGF) by serine/threonine protein kinase AKT |
| 07/24/2002 | CN1360582A Quinazoline derivs. |
| 07/24/2002 | CN1360581A Benzoylpyridazines |
| 07/24/2002 | CN1360577A Hydroxamic acid derivs. as matrix metalloprotease inhibitors |
| 07/24/2002 | CN1360571A Cinnamoylaminoalkyl-substd. benzenesulfonamide derivs. |
| 07/24/2002 | CN1360568A Diacylhydrazine derivs. |
| 07/24/2002 | CN1360507A Conjugates and method for production thereof, and their use for transporting molecules via biological membranes |
| 07/24/2002 | CN1360499A Pharmaceutical composition contg. fenofibrate and preparation method |
| 07/24/2002 | CN1359900A Metal protease inhibitor, preparing process thereof and pharmaceutical composition contg. same |
| 07/24/2002 | CN1359722A Process for preparing Chinese medicinal antihypertensive pill |
| 07/24/2002 | CN1359720A Health-care kudingcha tea for calming and lowering blood pressure |
| 07/24/2002 | CN1359717A Process for prepairng Chinese-medicinal ointment of treating uremia, renal hypertension and hyperlipomia |
| 07/24/2002 | CN1359703A Oral liquid for detoxicating and dispelling wind |
| 07/24/2002 | CN1359687A Medicine for treating cardiovascular and cerebrovascular infarction |
| 07/24/2002 | CN1359682A Breviscapine-phosphotide compound and its preparing process |
| 07/24/2002 | CN1087934C Use of phenalkylamines |
| 07/23/2002 | US6423870 Tricyclic compounds, preparation method and pharmaceutical compositions containing same |
| 07/23/2002 | US6423855 Prevention lysis; oxidation resistance |
| 07/23/2002 | US6423754 Method for treating hypercholesterolemia with polyallylamine polymers |
| 07/23/2002 | US6423752 Indane dimer compounds with smooth muscle relaxing and/or mast cell stabilizing and/or anti-inflammatory activity |
| 07/23/2002 | US6423744 Administering an amount of a leukotriene b4 (ltb4) antagonist, preferably a ltb4 receptor antagonistic, to a patient exhibiting adverse drug effect due to exogenous interleukin-2, to decrease the adverse effects |
| 07/23/2002 | US6423725 Analgesics |
| 07/23/2002 | US6423715 Thiazolobenzoheterocycles, their preparation and medicaments containing them |